Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
34%
OVERLAP
BY WEIGHT
BY WEIGHT
18
# OF OVERLAPPING HOLDINGS
BHCHX
40
HOLDINGS
49%
ALSO IN IXJ
IXJ
114
HOLDINGS
16%
ALSO IN BHCHX
SECTOR DRIFT (BHCHX minus IXJ)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BHCHX |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY AND COMPANY | 9.3% | 8.8% | 8.8% |
|
UNITEDHEALTH GROUP INCORPORATED | 7.3% | 4.0% | 4.0% |
|
MERCK & CO., INC. | 4.8% | 2.9% | 2.9% |
|
INTUITIVE SURGICAL, INC. | 5.8% | 2.8% | 2.8% |
|
BOSTON SCIENTIFIC CORPORATION | 5.3% | 2.3% | 2.3% |
BHCHX Overweight Relative to IXJ
 |
ARGENX SE ADR | 4.1% |
|
UNITEDHEALTH GROUP INCORPORATED | 3.3% |
|
UNITEDHEALTH GROUP INC | 3.3% |
 |
ICON PLC | 3.2% |
|
INTUITIVE SURGICAL, INC. | 3.0% |
|
INTUITIVE SURGICAL INC | 3.0% |
|
BOSTON SCIENTIFIC CORP | 3.0% |
|
BOSTON SCIENTIFIC CORPORATION | 3.0% |
|
VERTEX PHARMACEUTICALS INC | 3.0% |
|
VERTEX PHARMACEUTICALS INCORPORATED | 3.0% |
BHCHX Underweight Relative to IXJ
|
JOHNSON & JOHNSON | -5.3% |
|
ABBVIE INC | -4.6% |
|
ABBOTT LABORATORIES | -3.4% |
 |
ROCHE HOLDING LTD | -3.3% |
|
NOVARTIS AG | -3.3% |
 |
ASTRAZENECA PLC | -3.1% |
 |
NOVO NORDISK A/S-B | -3.1% |
|
AMGEN INC | -2.1% |
|
GILEAD SCIENCES INC | -2.0% |
|
PFIZER INC | -2.0% |